Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 4, 2004, Pages 379-387

  Pretorius, Mias ^a,b,c   McFarlane, Julie A ^b   Vaughan, Douglas E ^a,b   Brown, Nancy J ^b   Murphey, Laine J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; KALLIKREIN; KININ; LISINOPRIL; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; SMOKING; VENOUS BLOOD;

EID: 4744340779     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.06.004     Document Type: Article

References (30)

1. Elixhauser A, Klemstine K, Steiner C, Bierman A. Procedures in U.S. Hospitals, 1997. Healthcare Cost and Utilization Project Fact Book No. 2. Agency for Healthcare Research and Quality Publication No. 01-0016. Rockville (MD): Agency for Healthcare Research and Quality; 2001. Available from: URL: http://www.ahrq.gov/data/hcup/factbk2/factbk2.htm. Accessed Feb 2, 2004.
2. B. Stiller, J. Sonntag, I. Dahnert, V. Alexi-Meskishvili, R. Hetzer, T Fischer Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor Intensive Care Med 27 2001 193 200
3. M. Fung, P.G. Loubser, A. Undar, M. Mueller, C. Sun, W.N Sun Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits J Thorac Cardiovasc Surg 122 2001 113 122
4. M. Galinanes, C. Watson, U. Trivedi, D.J. Chambers, C.P. Young, G.E. Venn Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans Circulation 94 1996 II364 9
5. R.E. Kalfin, R.M. Engelman, J.A. Rousou, J.E. Flack III, D.W. Deaton, D.L Kreutzer Induction of interleukin-8 expression during cardiopulmonary bypass Circulation 88 1993 II401 6
6. C. Neuhof, O. Walter, F. Dapper, J. Bauer, B. Zickmann, E Fink Bradykinin and histamine generation with generalized enhancement of microvascular permeability in neonates, infants, and children undergoing cardiopulmonary bypass surgery Pediatr Crit Care Med 4 2003 299 304
7. D.J. Campbell, B. Dixon, A. Kladis, M. Kemme, J.D. Santamaria Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans Am J Physiol Regul Integr Comp Physiol 281 2001 R1059 R70
8. V.B. Conti, C. McQuitty Vasodilation and cardiopulmonary bypass - the role of bradykinin and the pulmonary vascular endothelium Chest 120 2001 1759 1761
9. M. Cugno, J. Nussberger, P. Biglioli, F. Alamanni, R. Coppola, A. Agostoni Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass - the importance of lung exclusion Chest 120 2001 1776 1782
10. Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass. Circulation 2003:3079-83.
11. F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine, L.T. Skeggs Hydrolysis of bradykinin by angiotensin-converting enzyme Circ Res 34 1974 824 827
12. P. Bunning, B. Holmquist, J.F. Riordan Substrate specificity and kinetic characteristics of angiotensin converting enzyme Biochemistry 22 1983 103 110
13. P. Bunning, J.F. Riordan Activation of angiotensin converting enzyme by monovalent anions Biochemistry 22 1983 110 116
14. F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine, L.T. Skeggs Purification and properties of angiotensin-converting enzyme from hog lung Circ Res 31 1972 356 366
15. L.J. Murphey, D.L. Hachey, D.E. Vaughan, N.J. Brown, J.D. Morrow Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assay Anal Biochem 292 2001 87 93
16. L.J. Murphey, D.L. Hachey, J.A. Oates, J.D. Morrow, N.J. Brown Metabolism of bradykinin In vivo in humans: Identification of BK1-5 as a stable plasma peptide metabolite J Pharmacol Exp Ther 294 2000 263 269
17. M. Cyr, Y. Lepage, C. Blais Jr, N. Gervais, M. Cugno, J.L Rouleau Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma Am J Physiol Heart Circ Physiol 281 2001 H275 83
18. P.M. Vanhoutte Endothelium and control of vascular function: state of the art lecture Hypertension 13 1989 658 667
19. N.J. Brown, J.V. Gainer, C.M. Stein, D.E. Vaughan Bradykinin stimulates tissue plasminogen activator release in human vasculature Hypertension 33 1999 1431 1435
20. C. Labinjoh, D.E. Newby, P. Dawson, N.R. Johnston, C.A. Ludlam, N.A Boon Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man Cardiovasc Res 47 2000 707 714
21. 2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway Circulation 102 2000 2190 2196
22. D.T. Smith, G.L. Hoetzer, J.J. Greiner, B.L. Stauffer, C.A. DeSouza Endothelial release of tissue-type plasminogen activator in the human forearm: role of nitric oxide J Cardiovasc Pharmacol 42 2003 311 314
23. M. Pretorius, D. Rosenbaum, D.E. Vaughan, N.J. Brown Angiotensin- converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin Circulation 107 2003 579 585
24. Y. Sugiyama, H. Yotsumoto, T. Okabe, F. Takaku Measurement of angiotensin-converting enzyme activity in intact human alveolar macrophages and effect of smoking Respiration 53 1988 153 157
25. M. Pretorius, D.A. Rosenbaum, J. Lefebvre, D.E. Vaughan, N.J. Brown Smoking impairs bradykinin-stimulated t-PA release Hypertension 39 2002 767 771
26. J. Rehbock, A. Chondromatidou, P. Buchinger, A. Hermann, M. Jochum Bradykinin stimulates interleukin-6 and interleukin-8 secretion of human decidua derived cells Br J Obstet Gynaecol 104 1997 495 499
27. F. Vandekerckhove, G. Opdenakker, M. Van Ranst, J.P. Lenaerts, W. Put, A Billiau Bradykinin induces interleukin-6 and synergizes with interleukin-1 Lymphokine Cytokine Res 10 1991 285 289
28. C.D. Huang, O. Tliba, R.A. Panettieri Jr, Y. Amrani Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone Am J Respir Cell Mol Biol 28 2003 330 338
29. P. Bruins, H. te Velthuis, A.P. Yazdanbakhsh, P.G. Jansen, F.W. van Hardevelt, E.M de Beaumont Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
30. D.J. Brull, J. Sanders, A. Rumley, G.D. Lowe, S.E. Humphries, H.E. Montgomery Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release Heart 87 2002 252 255